Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request, 70186-70187 [2014-27835]
Download as PDF
<![CDATA[
wreier-aviles on DSK4TPTVN1PROD with NOTICES
70186
Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices
not include any sensitive health
information, like medical records or
other individually identifiable health
information. In addition, do not include
any ‘‘[t]rade secret or any commercial or
financial information which is . . .
privileged or confidential,’’ as discussed
in Section 6(f) of the FTC Act, 15 U.S.C.
46(f), and FTC Rule 4.10(a)(2), 16 CFR
4.10(a)(2). In particular, do not include
competitively sensitive information
such as costs, sales statistics,
inventories, formulas, patterns, devices,
manufacturing processes, or customer
names.
If you want the Commission to give
your comment confidential treatment,
you must file it in paper form, with a
request for confidential treatment, and
you are required to follow the procedure
explained in FTC Rule 4.9(c), 16 CFR
4.9(c). Your comment will be kept
confidential only if the FTC General
Counsel grants your request in
accordance with the law and the public
interest.
Postal mail addressed to the
Commission is subject to delay due to
heightened security screening. As a
result, we encourage you to submit your
comment online, or to send it to the
Commission by courier or overnight
service. To make sure that the
Commission considers your online
comment, you must file it at https://
ftcpublic.commentworks.com/ftc/
amplifierrulepra2, by following the
instructions on the Web-based form. If
this Notice appears at https://
www.regulations.gov, you also may file
a comment through that Web site.
If you file your comment on paper,
write ‘‘Amplifier Rule: FTC File No.
P974222’’ on your comment and on the
envelope, and mail or deliver it to the
following address: Federal Trade
Commission, Office of the Secretary,
600 Pennsylvania Avenue NW., Suite
CC–5610 (Annex J), Washington, DC
20580, or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW.,
5th Floor, Suite 5610 (Annex J),
Washington, DC 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before December 26, 2014. You can find
VerDate Sep<11>2014
14:41 Nov 24, 2014
Jkt 235001
more information, including routine
uses permitted by the Privacy Act, in
the Commission’s privacy policy, at
https://www.ftc.gov/ftc/privacy.shtm.
Comments on the information
collection requirements subject to
review under the PRA should also be
submitted to OMB. If sent by U.S. mail,
address comments to: Office of
Information and Regulatory Affairs,
Office of Management and Budget,
Attention: Desk Officer for the Federal
Trade Commission, New Executive
Office Building, Docket Library, Room
10102, 725 17th Street NW.,
Washington, DC 20503. Comments sent
to OMB by U.S. postal mail, however,
are subject to delays due to heightened
security precautions. Thus, comments
instead should be sent by facsimile to
(202) 395–5167.
David C. Shonka,
Principal Deputy General Counsel.
[FR Doc. 2014–27894 Filed 11–24–14; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: HHS–OS–0990–0330–
30D]
Agency Information Collection
Activities; Submission to OMB for
Review and Approval; Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, has submitted an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB) for
review and approval. The ICR is for
extending the use of the approved
information collection assigned OMB
control number 0990–0330, scheduled
to expire on 12/31/14. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public on this ICR during the review
and approval period.
DATES: Comments on the ICR must be
received on or before December 26,
2014.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
When
submitting comments or requesting
information, please include the OMB
control number <OCN> and document
identifier HHS–OS–0990–0330 30D for
reference.
Information Collection Request Title:
Annual Appellant Climate SurveyOffice of Medicare Hearings and
Appeals (OMHA).
OMB No.: 0990–0330.
Abstract: The annual OMHA
Appellant Climate Survey is a survey of
Medicare beneficiaries, providers,
suppliers, or their representatives who
participated in a hearing before an
Administrative Law Judge (ALJ) from
the Office of Medicare Hearings and
Appeals (OMHA). Appellants
dissatisfied with the outcome of their
Level 2 Medicare appeal may request a
hearing before an OMHA ALJ. The
Appellant Climate Survey will be used
to measure appellant satisfaction with
their OMHA appeals experience, as
opposed to their satisfaction with a
specific ruling.
OMHA was established by the
Medicare Prescription Drug,
Improvement, and Modernization Act
(MMA) of 2003 (Pub. L. 108–173) and
became operational on July 1, 2005. The
MMA legislation and implementing
regulations issued on March 8, 2007
instituted a number of changes in the
appeals process. The MMA legislation
also directed the U.S. Department of
Health and Human Services to consider
the feasibility of conducting hearings
using telephone or video-teleconference
(VTC) technologies. In carrying out this
mandate, OMHA makes use of VTC to
provide appellants with a vast
nationwide network of access points for
hearings close to their homes. The first
three-year administration cycle of the
OMHA survey began in FY08 and a
second three-year cycle began in FY12.
The survey will continue to be
conducted annually over a three-year
period, beginning in FY15.
Likely Respondents: Survey
respondents will consist of Medicare
beneficiaries, providers, suppliers, or
their representatives who participated
in a hearing before an OMHA ALJ.
OMHA will draw a representative, nonredundant sample of appellants whose
cases have been closed in the last six
months.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\25NON1.SGM
25NON1
70187
Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Average
burden per
response
(in hours)
Total
burden
hours
Form name
Charged at rate of Healthcare Providers and Suppliers.
Charged at rate of Beneficiaries .......
Form A .............................................
240
1
11/60
44
Form A .............................................
160
1
11/60
29
Total ...........................................
...........................................................
400
1
11/60
73
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2014–27835 Filed 11–24–14; 8:45 am]
BILLING CODE 4150–46–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
Notice is hereby given that
the Office of Research Integrity (ORI)
has taken final action in the following
case:
Dr. Igor Dzhura, Vanderbilt
University: Based on an inquiry
conducted and admission obtained by
Vanderbilt University (VU) and
additional analysis conducted by ORI in
its oversight review, ORI found that Dr.
Igor Dzhura, former Senior Research
Associate, Department of Biomedical
Engineering, VU, engaged in research
misconduct in research supported by
U.S. Public Health Service (PHS) funds,
specifically National Heart, Lung, and
Blood Institute (NHLBI), National
Institutes of Health (NIH), grants R01
HL070250, R01 HL062494, P01
HL046681, and K08 HL03727, National
Institute of Arthritis and
Musculoskeletal and Skin Diseases
(NIAMS), NIH, grant R01 AR044864,
National Institute of Mental Health
(NIMH), NIH, grant R01 MH063232,
National Institute of Allergy and
Infectious Diseases (NIAID), NIH, grant
U01 AI06223, and National Cancer
wreier-aviles on DSK4TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
14:41 Nov 24, 2014
Jkt 235001
Number of
respondents
Number
responses per
respondent
Type of
respondent
Institute (NCI), NIH, grant U54
CA113007.
ORI found that Respondent engaged
in research misconduct by providing
falsified and/or fabricated data to his
supervisor and colleagues. Specifically,
Respondent:
• Submitted falsified cytosolic calcium
buffering experiments to his research
supervisor by misrepresenting
apparent action potential traces; these
actually were fluorescent calcium
transients merged with sodium
calcium exchange currents from a
different experiment; Respondent
admitted to falsely claiming ten
replicates for each trace when only
testing three to five cells
• falsified sodium calcium exchange
(NCX) activity in Very Long Chain
Acid Dehydrogenase Deficient
(VLCAD) mice versus wild type mice
in a PowerPoint presentation by
falsely labeling and manipulating
NCX data from a different experiment
testing an unrelated compound; the
effect was to falsely claim a difference
in NCX activity between the two
mouse phenotypes
• provided a falsified Figure 6C in a
manuscript submitted to Nature Cell
Biology, while claiming that the data
were based on Respondent’s memory
of his data that had purportedly been
collected and lost; Respondent
claimed to have tested one hundred
fifty (150) cells for their action
potential characteristics when the
experimental record only accounted
for approximately twenty (20).
ORI found that Respondent engaged
in research misconduct by falsifying
and/or fabricating the research record of
patch-clamp data. Specifically,
Respondent:
• Created a hierarchy of computer
folders containing duplicated and
renamed files; the falsified groups of
files included eighty-two (82) groups
of duplicated files with each group
containing two to twenty-one (2–21)
duplicates, which made it appear that
experiments were conducted when
they were not
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
• used the falsified and/or fabricated
data files in Figure 6 of a paper
published in the American Journal of
Physiology-Heart and Circulatory
Physiology (292(5):H2202–H2211,
2007), to represent Ca+ currents in
cardiac myocytes from CLCAD-/mice; specifically, Respondent
claimed that Figure 6 represented
results from seven (7) mice when the
data files were three (3) sets of
duplicated and renamed files plus one
additional data file. All of the data
files were part of larger groups of
identical duplicated and renamed
data files on the Respondent’s hard
drive.
ORI found that Respondent engaged
in research misconduct by submitting
and publishing multiple falsified and/or
fabricated action potential traces and
summary data in at least sixty-nine (69)
images in twelve (12) different figures
across seven (7) publications and three
(3) grant applications by duplication
and relabeling of traces; resizing,
modifying, and splicing different traces;
and modifying and/or duplicating bar
graphs.
The evidence established that
Respondent engaged in research
misconduct, as defined by the PHS
regulation, in that he significantly
departed from accepted research
practices by engaging in the intentional
and knowing fabrication and
falsification of data files.
Dr. Dzhura has entered into a
Voluntary Exclusion Agreement
(Agreement) and has voluntarily agreed
for a period of three (3) years, beginning
on October 29, 2014:
(1) To exclude himself from any
contracting or subcontracting with any
agency of the United States Government
and from eligibility or involvement in
nonprocurement programs of the United
States Government referred to as
‘‘covered transactions’’ pursuant to
HHS’ Implementation (2 CFR part 376 et
seq) of OMB Guidelines to Agencies on
Governmentwide Debarment and
Suspension, 2 CFR part 180 (collectively
the ‘‘Debarment Regulations’’);
E:\FR\FM\25NON1.SGM
25NON1
]]>Agencies
[Federal Register Volume 79, Number 227 (Tuesday, November 25, 2014)]
[Notices]
[Pages 70186-70187]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27835]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
[Document Identifier: HHS-OS-0990-0330-30D]
Agency Information Collection Activities; Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the Secretary (OS), Department of
Health and Human Services, has submitted an Information Collection
Request (ICR), described below, to the Office of Management and Budget
(OMB) for review and approval. The ICR is for extending the use of the
approved information collection assigned OMB control number 0990-0330,
scheduled to expire on 12/31/14. Comments submitted during the first
public review of this ICR will be provided to OMB. OMB will accept
further comments from the public on this ICR during the review and
approval period.
DATES: Comments on the ICR must be received on or before December 26,
2014.
ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Information Collection Clearance
staff, Information.CollectionClearance@hhs.gov or (202) 690-6162.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the OMB control number and document
identifier HHS-OS-0990-0330 30D for reference.
Information Collection Request Title: Annual Appellant Climate
Survey- Office of Medicare Hearings and Appeals (OMHA).
OMB No.: 0990-0330.
Abstract: The annual OMHA Appellant Climate Survey is a survey of
Medicare beneficiaries, providers, suppliers, or their representatives
who participated in a hearing before an Administrative Law Judge (ALJ)
from the Office of Medicare Hearings and Appeals (OMHA). Appellants
dissatisfied with the outcome of their Level 2 Medicare appeal may
request a hearing before an OMHA ALJ. The Appellant Climate Survey will
be used to measure appellant satisfaction with their OMHA appeals
experience, as opposed to their satisfaction with a specific ruling.
OMHA was established by the Medicare Prescription Drug,
Improvement, and Modernization Act (MMA) of 2003 (Pub. L. 108-173) and
became operational on July 1, 2005. The MMA legislation and
implementing regulations issued on March 8, 2007 instituted a number of
changes in the appeals process. The MMA legislation also directed the
U.S. Department of Health and Human Services to consider the
feasibility of conducting hearings using telephone or video-
teleconference (VTC) technologies. In carrying out this mandate, OMHA
makes use of VTC to provide appellants with a vast nationwide network
of access points for hearings close to their homes. The first three-
year administration cycle of the OMHA survey began in FY08 and a second
three-year cycle began in FY12. The survey will continue to be
conducted annually over a three-year period, beginning in FY15.
Likely Respondents: Survey respondents will consist of Medicare
beneficiaries, providers, suppliers, or their representatives who
participated in a hearing before an OMHA ALJ. OMHA will draw a
representative, non-redundant sample of appellants whose cases have
been closed in the last six months.
[[Page 70187]]
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Charged at rate of Healthcare Form A.......... 240 1 11/60 44
Providers and Suppliers.
Charged at rate of Form A.......... 160 1 11/60 29
Beneficiaries.
---------------------------------------------------------------
Total..................... ................ 400 1 11/60 73
----------------------------------------------------------------------------------------------------------------
OS specifically requests comments on (1) the necessity and utility
of the proposed information collection for the proper performance of
the agency's functions, (2) the accuracy of the estimated burden, (3)
ways to enhance the quality, utility, and clarity of the information to
be collected, and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2014-27835 Filed 11-24-14; 8:45 am]
BILLING CODE 4150-46-P
